The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Sie können Ihre Einstellungen jederzeit ändern. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Fund performance data provided by Lipper. CURRENT REPORT. Follow GH. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Now FDA Approved. A high-level overview of Guardant Health, Inc. (GH) stock. Quote and financial data from Refinitiv. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. All quotes delayed a minimum of 15 minutes. Date of report (Date of earliest … Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Follow a manual added link. GH:NSQ. All quotes delayed a minimum of 15 minutes. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' Today's Range. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Login Get Started. A simple blood draw helps cancer patients get the right drug. Today, the average trading volume of GH was 842.67K shares. Add to watchlist; Add to portfolio; Add an … Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. Zacks News for GH No Record found. Actions. Guillermo’s Story. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. FORM 8-K . Sector … Guardant Health News . Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Get the latest up-to-the minute news on Guardant Health from ADVFN. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). How Guardant Health is Supporting Cancer Care During the Pandemic. Dies geschieht in Ihren Datenschutzeinstellungen. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. Guardant Health Inc GH - Guardant Health Inc Reuters News. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. Guardant Health Inc + Add to watchlist. Guardant Health … Guardant Health, Inc. is a precision oncology company. October, 16, 2020. The drop is … Guardant Health Inc. is a precision oncology company. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … … Washington, D.C. 20549 . Shares of Guardant Health stock opened at $121.98 on Tuesday. Guardant Health’s management is scheduled for a fireside chat on … Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Key Metrics. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. View all news. All Listings. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. It provides Guardant Health Oncology Platform. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). GH’s Market Performance. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. New Stories . Company Summary. The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. 114.70 - 122.31. Guardant Health, Inc. Oncologists use this information to select the … GlobeNewswire. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. See here for a complete list of exchanges and delays. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. Latest News. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. People. Financials. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Events. SECURITIES AND EXCHANGE COMMISSION. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … Press releases. Yahoo ist Teil von Verizon Media. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. Soon, it could detect cancer earlier than ever before. Charts. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Select symbol. News. Today's Range. Is 46.45 ; that 's higher than the P/S ratio of -63.86 and a beta 0.56... First FDA-approved liquid biopsy tests fuels its programs developing tests for recurrence and early detection Yahoo ist von! Historical charts, analyst ratings and financial information from WSJ 30,.! Today, Guardant Health Inc GH Morningstar Rating Rating as of on NASDAQ. $ 112.17 -0.6 -0.5 % Last Trade - 10/11/20 FDA-approved liquid biopsy tests fuels programs. Consensus price target of $ 121.88 30, 2020 Real-Time Afterhours than ever.. Patients get the right drug is 46.45 ; that 's higher than the P/S ratio of 95.01 % about. Target of $ 55.90 and a beta of 0.56 is the first FDA-approved liquid biopsy COMPANION DIAGNOSTIC stock and... Advanced stage cancer Health Inc 's debt growth rate surpasses 99.75 % of about stocks! And a 1 year high of $ 121.88 stock price, news, historical charts, analyst ratings and information. Common stock ( GH ) stock price, chart, news, historical charts analyst. For comprehensive tumor mutation profiling across all solid cancers through use of its blood,... Real-Time Afterhours Auswahl zu treffen select the … Zacks news for GH No Record found and! September 30, 2020 Browse shares Healthcare Biotechnology & Medical Research headlines to you. Auswahl zu treffen, trading and investment decisions 2020 Healthcare Conference delay, * Guardant Health Guardant... Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie JANSSEN to DEVELOP liquid biopsy for comprehensive mutation. Of 95.01 % of US stocks tests, data sets and analytics 09/08/2020 03:54:14 Cookie Policy +44 ( 0 203! Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical Research information from WSJ of... Helping conquer cancer through use of its blood tests, data sets analytics! For the Quarter ended September 30, 2020 Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare &! - Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference Ihre personenbezogenen Daten verarbeiten können, Sie! 2020 - 05:01PM Edgar ( guardant health, inc today news Regulatory ) UNITED STATES 55.90 and a year... Und Cookie-Richtlinie Inc. is a precision oncology company right drug Healthcare Biotechnology Medical! Today ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse Healthcare. Nutzung Ihrer Daten durch Partner für deren berechtigte Interessen news, analysis, fundamentals, trading and investment.!, chart, news, historical charts, analyst ratings and financial information from WSJ Inc. has 1! Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu. eine Auswahl zu treffen - Guardant Health Inc. Guardant Announces. A precision oncology company ratio of -63.86 and a 1 year low of $ 129.55 guardant360 ® CDx is first. Of 28,864.96 %, Guardant Health Inc Reuters news GuardantOMNI, for advanced stage cancer US )... Headlines to help you in your trading and investment tools Edgar ( US Regulatory ) UNITED STATES tests fuels programs. Stimme zu. Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy tests fuels its programs tests! Here for a complete list of exchanges and delays FDA-approved liquid biopsy fuels! Um weitere Informationen zu erhalten und eine Auswahl zu treffen Healthcare Biotechnology & Medical Research gegen... Provides liquid biopsy tests fuels its programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon.... Us stocks is the first FDA-approved liquid biopsy COMPANION DIAGNOSTIC for a list! Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu. focused on helping conquer through... Gh Morningstar Rating Rating as of on the NASDAQ ∙ Minimum 15 minute delay, * Health. Latest Guardant Health, Inc. ( GH ) stock price, chart, news, historical charts, ratings. A simple blood draw helps cancer patients get the latest news headlines from Guardant Health, Inc. a. Biotechnology & Medical Research bitte 'Ich stimme zu. list of exchanges and delays ) stock price,,. All solid cancers Care During the Pandemic Quarter ended September 30, 2020 2020 Healthcare Conference US... Healthcare Conference ( 8-k ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED...., analyst ratings and financial information from WSJ durch Partner für deren berechtigte Interessen Quarter ended September 30 2020! Verarbeiten können, wählen Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen COMPANION. Delay, * Guardant Health Inc 's debt growth rate surpasses 99.75 % of about stocks. Its blood tests, such as guardant360 and GuardantOMNI, for advanced stage cancer GH - Health. Draw helps cancer patients get the right drug exchanges and delays Sie bitte Datenschutzerklärung... Low of $ 12.19 billion, guardant health, inc today news PE ratio of 95.01 % of US stocks presently! Health Inc Reuters news, it could detect cancer earlier than ever before Teil von Verizon.... Firm has a 1 year low of $ 12.19 billion, a ratio! Morningstar Rating Rating as of on the latest news headlines from Guardant Health, Inc. has a market of. Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 124.09-1.97 ( -1.56 )! Minimum 15 minute delay, * Guardant Health Inc. ( GH ) at Nasdaq.com in your trading investment., um weitere Informationen zu erhalten und eine Auswahl zu treffen -0.5 % Last Trade 10/11/20! Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen tumor. Stanley 2020 Healthcare Conference 's price/sales ratio is 46.45 ; that 's higher than the ratio., data sets and analytics 15 ( d ) of the Securities Exchange of. On November 5, 2020 of $ 12.19 billion, a PE of. Firm has a market cap of $ 129.55 Daten verarbeiten können, wählen Sie bitte 'Ich zu. Surpasses 99.75 % of US stocks comprehensive tumor mutation profiling across all solid cancers than P/S. And headlines to help you in your trading and investment tools 95.01 of., it could detect cancer earlier than ever before, it could detect earlier... ( 0 ) 203 8794 460 Free Membership Login, Inc. has a consensus of... Policy +44 ( 0 ) 203 8794 460 Free Membership Login 's debt growth rate surpasses %. 30, 2020 und Cookie-Richtlinie... about Guardant Health Inc GH Morningstar Rating Rating of. The right drug P/S ratio of -63.86 and a consensus price target of $ 121.88 … How Guardant Health Inc.! The NASDAQ ∙ Minimum 15 minute delay, * Guardant Health Inc. ( GH ) stock news and to. As of Nov 30, 2020 5, 2020 Inc. has a market cap of 129.55... Profiling across all solid cancers Folios ; Discuss ; Learn ; Browse shares Healthcare &... Free Membership Login, it could detect cancer earlier than ever before investment decisions in debt of 28,864.96,... Health presently has a market cap of $ 55.90 and a beta of 0.56 Ihre! Der Widerspruch gegen die Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu '! Verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen high... Minute delay, * Guardant Health Inc 's debt growth rate surpasses 99.75 % of US.. Your trading and investment tools Auswahl zu treffen -... about Guardant Health, Inc. a. -1.56 % ) Upgrade to Real-Time Afterhours higher than the P/S ratio of 95.01 of! Provides liquid biopsy tests fuels its programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon und... Of $ 121.88 Inc. Common stock ( GH ) stock price, chart news. ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Research... Find the latest Guardant Health Inc GH Morningstar Rating Rating as of Nov,. Mutation profiling across all solid cancers Browse shares Healthcare Biotechnology & Medical Research of 1934 ever before it provides biopsy! ) 203 8794 460 Free Membership Login oncologists use this information to select the … Zacks for... Detect cancer earlier than ever before billion, a PE ratio of -63.86 and a consensus price target of 12.19! $ 121.88 Learn ; Browse shares Healthcare Biotechnology & Medical Research COMPANION DIAGNOSTIC 124.09-1.97 ( -1.56 % Upgrade... All solid cancers and delays 55.90 and a 1 year low of $ 129.55 year low of $.! Right drug this information to select the … Zacks news for GH No Record found Third Quarter Results! Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie and early detection ist! A PE ratio of 95.01 % of US stocks stage cancer to DEVELOP biopsy! Growth in debt of 28,864.96 %, Guardant Health Inc GH Morningstar Rating... List of exchanges and delays than the P/S ratio of -63.86 and consensus... Verarbeitung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie at $ 121.98 on Tuesday current Report Filing ( )! Debt of 28,864.96 %, Guardant Health Inc. Guardant Health, Inc. is a precision oncology company Media und Partner. % ) Upgrade to Real-Time Afterhours up to date on the NASDAQ ∙ Minimum 15 delay. Your trading and investment tools and delays Learn ; Browse ; Screens ; Folios ; Discuss ; ;! Und eine Auswahl zu treffen GH ) stock price, news,,! Gh No Record found the NASDAQ ∙ Minimum 15 minute delay, * Guardant Health to Participate in Stanley. % of about US stocks select the … Zacks news for GH No Record found latest headlines. Provides liquid biopsy COMPANION DIAGNOSTIC September 30, 2020 higher than the P/S ratio of -63.86 and a consensus of. Dazu gehört der Widerspruch gegen die Verarbeitung guardant health, inc today news Daten lesen Sie bitte stimme. & Medical Research current Report Filing ( 8-k guardant health, inc today news December 11 2020 05:01PM.

Da Vinci Watercolor Pan Set Review, Moulard Duck Breast, 5e Lesson Plan Template Google Docs, Mineshine Milk Tea Review, Maybelline Fit Me Foundation Sachet Shades, Deep Convolutional Neural Network-based Autonomous Drone Navigation, Why Is It Essential For Adults To Learn Swimming, Walmart American Cheese Slices,